Rocket, Lab’s

Rocket Lab’s Neutron Countdown Intensifies as Options Pricing Highlights Deep Uncertainty

11.06.2026 - 06:17:16 | boerse-global.de

Traders pile into hedges as Neutron rocket debut nears. Despite 12% weekly drop, strong revenue, $2B cash, and new defense contracts underpin long-term outlook.

Rocket Lab Stock Slips but Options Signal Big Moves Ahead of Neutron Launch
Rocket - Rocket Lab’s Neutron Countdown Intensifies as Options Pricing Highlights Deep Uncertainty 11.06.2026 - Bild: über boerse-global.de

The options market is flashing a clear warning: traders are piling into hedges as Rocket Lab’s first flight of the Neutron rocket draws closer. On June 9, 158,000 contracts changed hands, pushing the put/call ratio to 0.69 — well above the typical 0.52 level. Implied volatility surged to roughly 105, signaling expectations of violent price swings in the weeks ahead.

The unease is understandable. The stock tumbled 8.2 percent last Friday, caught in a broad selloff that also punished the broader space sector. Over a seven-day stretch, the drop reached nearly 12 percent, dragging the shares to around €91.00. They have since recovered slightly to €94.60, but that still leaves them 29 percent below the all-time high of €133.80 set on May 27.

None of the slide erases the company’s formidable fundamental momentum. In the first quarter of 2026, revenue surged 63.5 percent to a record $200.3 million. Gross margin expanded to 38.2 percent, driven by the Space Systems segment, which now accounts for 68 percent of sales. The order backlog swelled to $2.2 billion — a 20 percent sequential increase and more than double the level of a year ago.

Rocket Lab’s cash position remains exceptionally strong at over $2 billion, giving management ample runway to fund the Neutron development without the pressure of a capital raise. The medium-lift rocket is the centerpiece of the company’s valuation story, and a formal launch window has now been filed with the Federal Aviation Administration: July 1 to December 31, 2026. That is the first time the debut timeframe has appeared in official paperwork.

Should investors sell immediately? Or is it worth buying Rocket Lab?

Progress on the ground is steady. The first flight hardware is being assembled at the integration facility in Virginia. Archimedes engines are moving through qualification testing, and milestones have been reached on the second stage and the reusable payload fairing. One setback occurred in January, when a first-stage pressure tank failed during a hydrostatic test; it has been replaced with a component produced on an automated fiber-layup machine.

Commercial demand is already materializing for a rocket that has never flown. Five Neutron launch contracts were signed in the first quarter alone, the first publicly disclosed bookings for the vehicle. The manifest for the smaller Electron rocket, meanwhile, grew by 31 new contracts, bringing the total mission count to more than 70.

Defense business is becoming an increasingly important pillar. In late May, Rocket Lab passed a critical technical review with the U.S. Space Development Agency for a satellite network focused on missile warning. Combined SDA awards now total more than $1.3 billion. A separate $90 million contract from the U.S. Space Force — the company’s first to build and operate geostationary satellites for the Heimdall space surveillance program — was signed in May.

The acquisition of Motiv Space Systems, completed recently, adds robotics and actuation technology already used on NASA’s Perseverance rover and the CADRE lunar rovers. The deal broadens Rocket Lab’s in-house capabilities and deepens its ties to government missions.

Rocket Lab at a turning point? This analysis reveals what investors need to know now.

Yet the share price continues to trade at a steep premium. The price-to-sales multiple stands at 88.79, a level that can be sustained only if Neutron flies on schedule and begins to disrupt the medium-lift market. Management has guided for second-quarter revenue of $225 million to $240 million, with an operating loss of up to $26 million. Deliver those numbers, and the growth narrative remains intact. A delay in the Neutron program, however, would likely test the 200-day moving average near €62.

For now, the stock hovers just above its 50-day line. The next few months will determine whether the record backlog and expanding defense contracts are enough to justify the current valuation — or whether the market’s growing caution is a sign of tougher times ahead.

Ad

Rocket Lab Stock: New Analysis - 11 June

Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Rocket Lab analysis...

en | US7731211089 | ROCKET | boerse | 69518562 |